bootstrapping

5 ms·

1.
by bootstrapping 6y ago
They are both CNS stimulants, but one is believed to be primarily a NDRI and the other a slow-release prodrug for a TAAR1 agonist. I have somewhat dissimilar responses to each, and the variation in utility is sufficiently well correlated t
2.
by bootstrapping 6y ago
This is a furphy. None of the comments here containing the word "calm" have, on review, made that claim. They are all personal anecdotal observations. Indeed there are also dissimilar observations. This is consistent with my e
3.
by bootstrapping 6y ago
> Take regular breaks from the medication As others have said, this is definitely something you must discuss with your personal brain care specialist first. What others have not suggested, and again this is something I have been able to
4.
by bootstrapping 6y ago
I'll echo this; I'm a serial founder who was diagnosed with ADHD in his mid-forties. The stimulant medications do not make me "high", do not provide any kind of buzz. Rather, they have a moderating effect. Explaining
5.
by bootstrapping 8y ago
If he or she does have some good ideas later, that real-world industry experience might come in handy.
6.
by bootstrapping 8y ago
That's one thing about bootstrapping, your P&L practically mirrors the cashflow statement so we had to be profitable from the get-go. We're well past that take-off stage where I was unsure if the business was going to fly or
7.
by bootstrapping 8y ago
> bootstrapping success stories often remain unknown Bingo. I don't even want to be noticed (hence this throwaway account). My startup has taken over an entire national B2B SaaS market segment but our major competitor hasn't re